Richard Rothen FP

Recommended Articles

• Does the Sun Really Help Treat Eczema?

  For a long time, it has been part of cultural knowledge that exposure to sunlight can help treat eczema. Now, it is medically agreed that eczema can be treated using UV light. But does this mean that you should go out and get yourself sunburnt?To answer this question, first, you have to consider the...

• What are the Treatment Options for Hernia

  Hernia occurs when an organ protrudes through an opening or a tissue that keeps it in place. There are several types of hernia including inguinal, incisional, hiatal, and more. While some hernias have visible symptoms such as a lump or acidity in stomach, others are asymptotic. The latter type of...

• The History of Autism

  Introduction Science has come a long way since the year 1908 when autism was first discovered. Autism has been referred to as a range of neuropsychological conditions. But the question arises where and how did the term autism originate and how has it changed over time? Some people might think that...

• The Side Effects of Xanax

  What Is Xanax?The generic name for Xanax is alprazolam and this is a benzodiazepine. Xanax was first introduced in 1976. This drug has an impact on the unbalanced chemicals in the brain of people who have anxiety. It is therefore prescribed for treating mental health problems which are linked with...

• What are Eye Floaters?

  Eye floaters are small, moving specks on the eyeball that often occur in one's field of vision. These grey or black dots, become more prominent while looking at a bright object. If the floaters are large they may shadow vision, but in most cases, eye floaters are harmless. People often neglect or...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...